A Brush with Climate, for example, is developing workshops to empower hairdressers to steer conversations toward climate ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

A judge issued her order after Trump officials continually refused to retrieve Abrego Garcia, saying they defied a ...

Q1 2025 Earnings Conference Call April 15, 2025 9:40 AM ETCompany ParticipantsGregory Lundberg - Investor RelationsJohn Wren ...

iGEM uOttawa seeks sustainable semaglutide production amid Ozempic shortage. Credit: Amelia Adams Phytogene uses Nicotiana benthamiana, a relative of the tobacco plant, to produce medications like GLP ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The investment aims to increase manufacturing ...

This expansion aims to double the plant's size and enhance production capacity for diabetes and obesity treatments, including its blockbuster drugs Ozempic and Wegovy. The announcement ...

As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 ...

April 14 (UPI) --The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States.

SAO PAULO (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The ...